HW
ABMD

Hancock Whitney’s Abiomed Inc ABMD Stock Holding History

Hancock Whitney’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,965
Closed -$483K – 656
2022
Q3 		$483K Hold
1,965
– – 0.02% 422
2022
Q2 		$486K Sell
1,965
-13
-0.7% -$3.51K 0.02% 426
2022
Q1 		$655K Buy
1,978
+1
+0.1% +$308 0.02% 400
2021
Q4 		$710K Buy
1,977
+2
+0.1% +$676 0.02% 395
2021
Q3 		$643K Sell
1,975
-17
-0.9% -$5.76K 0.02% 406
2021
Q2 		$622K Sell
1,992
-4
-0.2% -$1.23K 0.02% 501
2021
Q1 		$636K Sell
1,996
-54
-3% -$17.3K 0.02% 488
2020
Q4 		$665K Sell
2,050
-153
-7% -$42.3K 0.02% 457
2020
Q3 		$610K Sell
2,203
-12
-0.5% -$3.46K 0.02% 469
2020
Q2 		$535K Buy
2,215
+8
+0.4% +$1.61K 0.02% 495
2020
Q1 		$320K Sell
2,207
-10
-0.5% -$1.66K 0.01% 626
2019
Q4 		$378K Buy
2,217
+129
+6% +$23.9K 0.01% 623
2019
Q3 		$371K Sell
2,088
-180
-8% -$38.9K 0.01% 651
2019
Q2 		$591K Sell
2,268
-9
-0.4% -$2.39K 0.02% 583
2019
Q1 		$651K Buy
2,277
+230
+11% +$76.4K 0.02% 556
2018
Q4 		$665K Sell
2,047
-29
-1% -$10.1K 0.02% 503
2018
Q3 		$933K Buy
+2,076
New +$818K 0.03% 492

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Hancock Whitney's ABMD Position: Q4 2022 in Review

Hancock Whitney sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,965 shares — an estimated $483K sold.

Hancock Whitney first reported a position in ABMD in Q3 2018 and held it in 17 quarters. The position peaked at $933K in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Hancock Whitney reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Hancock Whitney sold 1,965 Abiomed Inc shares in Q4 2022, an estimated $483K.
  • Hancock Whitney first reported a position in Abiomed Inc in Q3 2018 and held it in 17 quarters.
  • Hancock Whitney's Abiomed Inc position peaked at $933K in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Hancock Whitney's 13F filing for Q4 2022, filed 3 Feb 2023.